Hospital-based use of thromboprophylaxis in patients with COVID-19

por Spyropoulos, Alex C, Ageno, Walter, Barnathan, Elliot S
Publicado 2020

Updated Renal Dosage Recommendations for Rivaroxaban in Patients Experiencing or at Risk of Thromboembolic Disease

por Volkl, Albert A., Moore, Kenneth Todd, Haskell, Lloyd, Barnathan, Elliot S.
Publicado 2023

Systemic inflammatory profile and response to anti-tumor necrosis factor therapy in chronic obstructive pulmonary disease

por Loza, Matthew J, Watt, Rosemary, Baribaud, Frédéric, Barnathan, Elliot S, Rennard, Stephen I
Publicado 2012

Utility of animal and in vivo experimental infection of humans with rhinoviruses in the development of therapeutic agents for viral exacerbations of asthma and chronic obstructive...

por Del Vecchio, Alfred M., Branigan, Patrick J., Barnathan, Elliot S., Flavin, Susan K., Silkoff, Philip E., Turner, Ronald B.
Publicado 2015

Benefit–Risk of Rivaroxaban for Extended Thromboprophylaxis After Hospitalization for Medical Illness: Pooled Analysis From MAGELLAN and MARINER

por Raskob, Gary E., Spyropoulos, Alex C., Spiro, Theodore E., Lu, Wentao, Yuan, Zhong, Levitan, Bennett, Suh, Eunyoung, Barnathan, Elliot S.
Publicado 2021

Modified IMPROVE VTE Risk Score and Elevated D-Dimer Identify a High Venous Thromboembolism Risk in Acutely Ill Medical Population for Extended Thromboprophylaxis

por Spyropoulos, Alex C., Lipardi, Concetta, Xu, Jianfeng, Peluso, Colleen, Spiro, Theodore E., De Sanctis, Yoriko, Barnathan, Elliot S., Raskob, Gary E.
Publicado 2020

Extended Thromboprophylaxis in Hospitalized Patients with Heart Failure: A Post Hoc Analysis of the MAGELLAN Study

por Spyropoulos, Alex C., Raskob, Gary E., Spiro, Theodore E., Lu, Wentao, De Sanctis, Yoriko, Albanese, John, Mebazaa, Alexandre, Barnathan, Elliot S.
Publicado 2022

Comparative Risk Assessment of Severe Uterine Bleeding Following Exposure to Direct Oral Anticoagulants: A Network Study Across Four Observational Databases in the USA

por Weaver, James, Shoaibi, Azza, Truong, Huy Q., Larbi, Leila, Wu, Shujian, Wildgoose, Peter, Rao, Gowtham, Freedman, Amy, Wang, Lu, Yuan, Zhong, Barnathan, Elliot
Publicado 2021

Rivaroxaban for Prevention of Thrombotic Events, Hospitalization, and Death in Outpatients With COVID-19: A Randomized Clinical Trial

por Piazza, Gregory, Spyropoulos, Alex C., Hsia, Judith, Goldin, Mark, Towner, William J., Go, Alan S., Bull, Todd M., Weng, Stephen, Lipardi, Concetta, Barnathan, Elliot S., Bonaca, Marc P.
Publicado 2023

Validated and longitudinally stable asthma phenotypes based on cluster analysis of the ADEPT study

por Loza, Matthew J., Djukanovic, Ratko, Chung, Kian Fan, Horowitz, Daniel, Ma, Keying, Branigan, Patrick, Barnathan, Elliot S., Susulic, Vedrana S., Silkoff, Philip E., Sterk, Peter J., Baribaud, Frédéric
Publicado 2016

Improved Benefit Risk Profile of Rivaroxaban in a Subpopulation of the MAGELLAN Study

por Spyropoulos, Alex C., Lipardi, Concetta, Xu, Jianfeng, Lu, Wentao, Suh, Eunyoung, Yuan, Zhong, Levitan, Bennett, Sugarmann, Chiara, De Sanctis, Yoriko, Spiro, Theodore E., Barnathan, Elliot S., Raskob, Gary E.
Publicado 2019

Rationale and design for the study of rivaroxaban to reduce thrombotic events, hospitalization and death in outpatients with COVID-19: The PREVENT-HD study

por Capell, Warren H., Barnathan, Elliot S., Piazza, Gregory, Spyropoulos, Alex C., Hsia, Judith, Bull, Scott, Lipardi, Concetta, Sugarmann, Chiara, Suh, Eunyoung, Rao, Jaya Prakash, Hiatt, William R., Bonaca, Marc P.
Publicado 2021

Risk of Severe Bleeding With Extended Rivaroxaban to Prevent Venous Thromboembolism in Acute Medically Ill Patients With Bronchiectasis

por Lipardi, Concetta, Elliott, C. Gregory, Sugarmann, Chiara L., Haskell, Lloyd, Spyropoulos, Alex C., Raskob, Gary E., Xu, Jianfeng, Lu, Wentao, Marsigliano, Jessica, Spiro, Theodore, Yuan, Zhong, Wu, Shujian, Barnathan, Elliot S.
Publicado 2021

Association Between Asymptomatic Proximal Deep Vein Thrombosis and Mortality in Acutely Ill Medical Patients

por Raskob, Gary E., Spyropoulos, Alex C., Cohen, Alexander T., Weitz, Jeffrey I., Ageno, Walter, De Sanctis, Yoriko, Lu, Wentao, Xu, Jianfeng, Albanese, John, Sugarmann, Chiara, Weber, Traci, Lipardi, Concetta, Spiro, Theodore E., Barnathan, Elliot S.
Publicado 2021

Airway Inflammation and Illness Severity in Response to Experimental Rhinovirus Infection in Asthma

por Zhu, Jie, Message, Simon D., Qiu, Yusheng, Mallia, Patrick, Kebadze, Tatiana, Contoli, Marco, Ward, Christine K., Barnathan, Elliot S., Mascelli, Mary Ann, Kon, Onn M., Papi, Alberto, Stanciu, Luminita A., Jeffery, Peter K., Johnston, Sebastian L.
Publicado 2014

Bronchial mucosal IFN-α/β and pattern recognition receptor expression in patients with experimental rhinovirus-induced asthma exacerbations

por Zhu, Jie, Message, Simon D., Mallia, Patrick, Kebadze, Tatiana, Contoli, Marco, Ward, Christine K., Barnathan, Elliot S., Mascelli, Mary Ann, Kon, Onn M., Papi, Alberto, Stanciu, Luminita A., Edwards, Michael R., Jeffery, Peter K., Johnston, Sebastian L.
Publicado 2019

Post-Discharge Prophylaxis With Rivaroxaban Reduces Fatal and Major Thromboembolic Events in Medically Ill Patients

por Spyropoulos, Alex C., Ageno, Walter, Albers, Gregory W., Elliott, C. Gregory, Halperin, Jonathan L., Hiatt, William R., Maynard, Gregory A., Steg, P. Gabriel, Weitz, Jeffrey I., Lu, Wentao, Spiro, Theodore E., Barnathan, Elliot S., Raskob, Gary. E.
Publicado 2020

Rivaroxaban Plus Aspirin for Extended Thromboprophylaxis in Acutely Ill Medical Patients: Insights from the MARINER Trial

por Spyropoulos, Alex C., Goldin, Mark, Ageno, Walter, Albers, Gregory W., Elliott, C. Gregory, Hiatt, William R., Halperin, Jonathan L., Maynard, Gregory, Steg, P. Gabriel, Weitz, Jeffrey I., Spiro, Theodore E., Lu, Wentao, Marsigliano, Jessica, Raskob, Gary E., Barnathan, Elliot S.
Publicado 2022

Benefit–Risk Assessment of Rivaroxaban for Extended Thromboprophylaxis After Hospitalization for Medical Illness

por Raskob, Gary E., Ageno, Walter, Albers, Gregory, Elliott, C. Gregory, Halperin, Jonathan, Maynard, Gregory, Steg, Philippe Gabriel, Weitz, Jeffrey I., Albanese, John, Yuan, Zhong, Levitan, Bennett, Lu, Wentao, Suh, Eun Young, Spiro, Theodore, Lipardi, Concetta, Barnathan, Elliot S., Spyropoulos, Alex C.
Publicado 2022

Scout – sarcoidosis outcomes taskforce. A systematic review of outcomes to inform the development of a core outcome set for pulmonary sarcoidosis

por Harman, Nicola L, Gorst, Sarah L, Williamson, Paula R, Barnathan, Elliot S, Baughman, Robert P, Judson, Marc A, Junk, Heidi, Kampstra, Nynke A, Sullivan, Eugene J, Victorson, David E, Walton, Marc, AL-Hakim, Tamara, Nabulsi, Hana, Singh, Noopur, Grutters, Jan C, Culver, Daniel A
Publicado 2021